ENGN: enGene Holdings Inc

ENGN新闻

• 10:16 Citizens重申Engene股票市场表现优于大盘评级，目标价21美元
• 10:15 Citizens reiterates Market Outperform rating on Engene stock with $21 target
• 21:00 enGene Holdings: A Potential Oncology Entrant (NASDAQ:ENGN)
• 12:29 H.C. Wainwright 重申 Engene 股票为"买入"评级，看好其膀胱癌治疗优势
• 12:28 Engene stock remains a Buy at H.C. Wainwright on NMIBC treatment advantages
• 09:43 CG Oncology Undervalued Going Into A Busy 2026 (NASDAQ:CGON)
• 21:10 enGene完成膀胱癌治疗试验患者招募
• 21:09 enGene completes enrollment in bladder cancer treatment trial
• 12:37 H.C. Wainwright维持Engene股票买入评级，因detalimogene加入FDA试点计划
• 12:35 H.C. Wainwright maintains Buy rating on Engene stock as detalimogene joins FDA pilot program
• 14:59 enGene股价上涨，FDA选择其膀胱癌疗法参与CMC试点计划
• 14:56 enGene stock rises after FDA selects bladder cancer therapy for CMC pilot program
• 12:47 FDA选择enGene膀胱癌疗法参与开发计划
• 12:42 FDA selects enGene’s bladder cancer therapy for development program
• 05:34 enGene定价1.3亿美元股票和权证公开发行
• 05:33 enGene prices $130 million public offering of shares and warrants
• 21:12 enGene宣布普通股承销公开发行
• 21:10 enGene announces underwritten public offering of common shares